Cytokines at the Interplay Between Asthma and Atherosclerosis?

Area of Science:

• Immunology
• Cardiology
• Pulmonology

Background:

• Cardiovascular disease (CVD) is a known comorbidity in chronic inflammatory conditions.
• Evidence linking asthma, a prevalent respiratory disease, to CVD is limited and mechanisms are poorly understood.
• Inflammatory signaling is increasingly recognized as a factor in cardiovascular events.

Purpose of the Study:

• To review the relationship between asthma and cardiovascular disease.
• To investigate the role of specific cytokines in vascular dysfunction and atherosclerosis within this context.
• To identify potential therapeutic implications and areas for future research.

Main Methods:

• Literature review focusing on epidemiological and clinical data.
• Analysis of cytokine networks involved in inflammatory signaling.
• Examination of cytokine contributions to vascular dysfunction and atherosclerosis.

Main Results:

• The precise link between asthma and CVD remains unclear, with non-univocal data.
• Inflammatory regulation in asthma differs from that typically seen in atherosclerosis.
• Specific cytokines (IL-4, IL-6, IL-9, IL-17A, IL-33, IFN-γ, TNF-α) are implicated in vascular dysfunction.

Conclusions:

• Cytokine networks play a crucial role in the relationship between asthma and cardiovascular disease.
• Understanding these distinct inflammatory pathways is essential for developing targeted therapies.
• Further research is needed to elucidate mechanisms and identify therapeutic strategies for managing CVD in asthma patients.